Why Is TRULIEVE CANNABIS CO (TRLV) Stock Up Today?

TRLV stock rose 5.03% to $11.89 on Friday, driven by a combination of analyst activity and recent earnings performance. The stock opened at $11.30 and reached a session high of $11.89 at 10:30 AM ET before closing near the top of its range. The move came amid renewed analyst optimism and a recent earnings beat.

What Happened

Trulieve Cannabis Co. saw a significant price increase following a series of analyst actions. Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a $15 price target. The firm also reiterated its Overweight stance in a separate report. These developments came after Trulieve reported Q2 adjusted earnings per share of $0.11, exceeding the $0.06 estimate. The company also generated $271 million in sales, beating the $268.494 million forecast. Additionally, the CEO announced the termination of a 10b5-1 share sale plan after completing the first tranche of 2.5 million shares.

What The Data Shows

The stock traded with a volume of 0.4 million shares, which is 0.3 times the 3-month daily average. The price rose from a morning low of $11.10 to a high of $11.89. Trulieve’s fundamentals remain challenging, with a net margin of -41.6% and a revenue decline of 3.9% in the trailing twelve months. The stock currently trades within its 52-week range of $7.82 to $12.30. Recent insider transactions show three sales totaling $14.7 million by CEO Kim Rivers over the last 90 days, with the most recent filing on June 26, 2026.

What To Watch

Trulieve’s stock is set to continue under the microscope as analysts adjust their coverage and the company moves forward with its strategic initiatives. Investors should monitor the firm’s next earnings report and any further analyst updates for additional directional clues.